...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazole derivatives as nonpeptidic angiotensin II AT1 receptor antagonists.
【24h】

Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazole derivatives as nonpeptidic angiotensin II AT1 receptor antagonists.

机译:6取代氨基羰基苯并咪唑衍生物的设计,合成及生物学评价为非肽血管紧张素II AT1受体拮抗剂。

获取原文
获取原文并翻译 | 示例

摘要

A series of 6-substituted aminocarbonyl benzimidazole derivatives were designed and synthesized as nonpeptidic angiotensin II AT(1) receptor antagonists. The preliminary pharmacological evaluation revealed nanomolar AT(1) receptor binding affinity and good AT(1) receptor selectivity over AT(2) receptor for all compounds of the series, a potent antagonistic activity in isolated rabbit aortic strip functional assay for compounds 6b, 6d and 6i was also demonstrated. Furthermore, evaluation in spontaneous hypertensive rats and a preliminary toxicity evaluation showed that compound 6i is an orally active AT(1) receptor antagonist with low toxicity.
机译:将一系列6取代的氨基羰基苯并咪唑衍生物设计并合成为(1)受体拮抗剂的非肽血管紧张素II。 初步药理学评价揭示(1)受体结合亲和力的纳米摩尔,擅长(1)对(2)受体的所有化合物的(2)受体的选择性,用于组化合物6b,6d的分离的兔主动脉带功能测定中有效的拮抗活性。 和6i也被证明。 此外,在自发性高血压大鼠和初步毒性评价中的评估表明,化合物6i在(1)受体拮抗剂上具有低毒性的口腔活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号